SERATEC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SERATEC Trademark

Serial Number: 79250594 • Registration: 6430382

SERATEC is a trademark filed by SERATEC Gesellschaft für Biotechnologie mbH on August 28, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SERATEC Gesellschaft für Biotechnologie mbH

Ernst-Ruhstrat-Straße 5

Entity Type: 99

Trademark Details

Filing Date

August 28, 2018

Registration Date

July 27, 2021

Published for Opposition

May 11, 2021

Goods & Services

Downloadable computer software for computers, mobile phones, smartphones, tablets, PDAs and other mobile electronic devices for the presentation, analysis, monitoring and storage of medical test results; downloadable computer software for computers, mobile phones, smartphones, tablets, PDAs and other mobile electronic devices for the presentation, analysis, monitoring and storage of test results relating to drug tests, pregnancy tests, ovulation tests and/or PSA tests

In vitro diagnostic preparations for medical purposes; in vitro diagnostic agents for medical purposes; in vitro diagnostics for forensic purposes; medical diagnostic reagents used in immunochromatographic quick tests; clinical medical reagents, namely, reagents for clinical-chemical tests; medical diagnostic test strips for the examination of food and foodstuffs; medical diagnostic test strips for conducting immunochromatographic tests; medical diagnostic test strips for conducting chemical tests; medical test kit comprised primarily of diagnostic preparations for detecting body fluids; medical test kit comprised primarily of diagnostic preparations for determining body fluids; medical test kit comprised primarily of diagnostic preparations for detecting substances in body fluids; drug testing kits comprised of medical diagnostic reagents and assays for testing substances in body fluids; medical test kit comprised primarily of diagnostic preparations for quantifying substances in body fluids; pregnancy test kits for home use; ovulation test kits; medical diagnostic test strips for PSA analysis; haemoglobin tests for medical purposes; medical test kit comprised primarily of diagnostic preparations for detecting human haemoglobin; medical test kit comprised primarily of diagnostic preparations for detecting saliva; medical test kit comprised primarily of diagnostic preparations for detecting seminal fluid; reagents for medical use; clinical medical reagents for forensic use; clinical medical reagents for conducting immunochromatographic tests; clinical medical reagents for conducting chemical tests; immunoassay reagents for medical use; clinical medical immunoassay reagents for forensic use; clinical medical immunoassay reagents for conducting immunochromatographic tests; clinical medical immunoassay reagents for conducting chemical tests; diagnostic kits consisting primarily of medical antibodies; diagnostic kits consisting primarily of antibodies for forensic purposes; diagnostic kits consisting primarily of antibodies for conducting immunochromatographic tests

Medical diagnostic apparatus, analytical apparatus for medical purposes; medical diagnostic testing apparatus for forensic purposes; medical diagnostic testing apparatus for immunochromatography; medical diagnostic testing apparatus for detecting body fluids; medical diagnostic testing apparatus for determining body fluids; medical diagnostic testing apparatus for detecting substances in body fluids; medical diagnostic testing apparatus for determining substances in body fluids; medical diagnostic testing apparatus for quantifying substances in body fluids; medical diagnostic testing apparatus for detecting drugs; medical diagnostic testing apparatus for identifying drugs; medical diagnostic testing apparatus for quantifying a drug in a body fluid; medical diagnostic testing apparatus for detecting PSA; medical diagnostic testing apparatus for quantifying PSA in a body fluid; medical diagnostic testing apparatus for diagnosis of pregnancy; medical diagnostic testing apparatus for diagnosis of ovulation; medical diagnostic testing apparatus for detecting haemoglobin; medical diagnostic testing apparatus for detecting saliva; medical diagnostic testing apparatus for detecting seminal fluid

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 1, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2021 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 27, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 27, 2021 R.PR
NOTIFICATION PROCESSED BY IB
May 16, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 11, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 11, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 21, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 21, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2021 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 1, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 19, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jan 19, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jan 19, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 10, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 20, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 20, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 20, 2020 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 3, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 15, 2020 OPNS
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 8, 2020 RCCK
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 2, 2020 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 20, 2020 RCSC
ASSIGNED TO LIE
Jan 30, 2020 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 8, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 8, 2019 GNSL
SUSPENSION LETTER WRITTEN
Jul 8, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2019 REAP
NON-FINAL ACTION MAILED
Jun 6, 2019 CNRT
NON-FINAL ACTION WRITTEN
Jun 6, 2019 CNRT
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
May 15, 2019 CREV
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 29, 2019 CRCV
REFUSAL PROCESSED BY IB
Mar 16, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 23, 2019 RFCS
REFUSAL PROCESSED BY MPU
Feb 23, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 16, 2019 RFCR
NON-FINAL ACTION WRITTEN
Feb 15, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 9, 2019 MAFR
ASSIGNED TO EXAMINER
Feb 5, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 4, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 31, 2019 REPR